Literature DB >> 22795058

Technical performance scores in congenital cardiac operations: a quality assessment initiative.

John M Karamichalis1, Steven D Colan, Meena Nathan, Frank A Pigula, Christopher Baird, Gerald Marx, Sitaram M Emani, Tal Geva, Francis E Fynn-Thompson, Hua Liu, John E Mayer, Pedro J del Nido.   

Abstract

BACKGROUND: Technical performance in congenital cardiac operations and its association with clinical outcomes was previously examined in infants and neonates. The purpose of this study was the development and implementation of a system for measuring technical performance in the majority of congenital cardiac operations to be used as a surgeon's self-assessment tool.
METHODS: Using the methodologic framework piloted at our institution, measures of technical performance were created for more than 90% of all congenital cardiac operations. Each operation was divided into multiple subprocedures to be assessed separately. Criteria for technical scores were created using a consensus panel of senior clinicians and were based primarily on the predischarge echocardiographic findings and need for early postoperative reinterventions. This system of procedure modules was then piloted by prospectively assigning technical scores to all patients undergoing operations.
RESULTS: Thirty modules were created covering more than 90% of the cardiac operations performed. One hundred eighty-five patients were enlisted. One hundred one (54.6%) cases were scored as class 1 (highest), 46 (24.9%) cases as class 2, 22 (11.9%) cases as class 3 (lowest); 16 cases (8.6%) could not be scored. The results were further analyzed by RACHS (Risk Adjustment for Congenital Heart Surgery) categories and outcomes. Valve-procedure-specific criteria were calibrated to reflect specific echocardiographic measurements.
CONCLUSIONS: The development and implementation of a broad technical performance self-assessment system for congenital cardiac operations is possible. Based on this scoring system, the impact of a less than optimal (2 or 3) technical score depends on case risk category, with higher mortality in the higher risk group, and increased resource use for lower risk procedures.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22795058     DOI: 10.1016/j.athoracsur.2012.05.014

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Impact of Variability in Echocardiographic Interpretation on Assessment of Adequacy of Repair Following Congenital Heart Surgery: A Pilot Study.

Authors:  Anitha Parthiban; Jami C Levine; Meena Nathan; Jennifer A Marshall; Girish S Shirali; Stephen D Simon; Steve D Colan; Jane W Newburger; Geetha Raghuveer
Journal:  Pediatr Cardiol       Date:  2015-09-10       Impact factor: 1.655

2.  Impact of Major Residual Lesions on Outcomes After Surgery for Congenital Heart Disease.

Authors:  Meena Nathan; Jami C Levine; Maria I Van Rompay; Linda M Lambert; Felicia L Trachtenberg; Steven D Colan; Iki Adachi; Brett R Anderson; Emile A Bacha; Aaron Eckhauser; J William Gaynor; Eric M Graham; Benjamin Goot; Jeffrey P Jacobs; Rija John; Jonathan R Kaltman; Kirk R Kanter; Carlos M Mery; L LuAnn Minich; Richard Ohye; David Overman; Christian Pizarro; Geetha Raghuveer; Marcus S Schamberger; Steven M Schwartz; Shanthi L Narasimhan; Michael D Taylor; Ke Wang; Jane W Newburger
Journal:  J Am Coll Cardiol       Date:  2021-05-18       Impact factor: 24.094

3.  Application of the Boston Technical Performance Score to intraoperative echocardiography.

Authors:  Hannah R Bellsham-Revell; Antigoni Deri; Silvia Caroli; Andrew Durward; Owen I Miller; Sujeev Mathur; Jelena Saundankar; David R Anderson; B Conal Austin; Caner Salih; Kuberan Pushparajah; John M Simpson
Journal:  Echo Res Pract       Date:  2019-07-09

4.  Depicting adverse events in cardiac theatre: the preliminary conception of the RECORD model.

Authors:  Haralabos Parissis; Lorraine Mc Grath-Soo; Bassel Al-Alao; Alan Soo
Journal:  J Cardiothorac Surg       Date:  2013-03-19       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.